{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:28:41Z","timestamp":1789072121313,"version":"build-2803163510"},"reference-count":158,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ymthe.2021.09.001","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T23:39:51Z","timestamp":1631230791000},"page":"3205-3218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Understanding and overcoming adverse consequences of genome editing on hematopoietic stem and progenitor cells"],"prefix":"10.1016","volume":"29","author":[{"given":"Byung-Chul","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9743-9006","authenticated-orcid":false,"given":"Richard J.","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7645-838X","authenticated-orcid":false,"given":"Cynthia E.","family":"Dunbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2021.09.001_bib1","doi-asserted-by":"crossref","first-page":"eaan4672","DOI":"10.1126\/science.aan4672","article-title":"Gene therapy comes of age","volume":"359","author":"Dunbar","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2021.09.001_bib2","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nature15818","article-title":"Gene therapy returns to centre stage","volume":"526","author":"Naldini","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.09.001_bib3","doi-asserted-by":"crossref","first-page":"618378","DOI":"10.3389\/fgeed.2021.618378","article-title":"Gene Editing of Hematopoietic Stem Cells: Hopes and Hurdles Toward Clinical Translation","volume":"3","author":"Ferrari","year":"2021","journal-title":"Front. Genome Ed."},{"key":"10.1016\/j.ymthe.2021.09.001_bib4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41586-020-1978-5","article-title":"The promise and challenge of therapeutic genome editing","volume":"578","author":"Doudna","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.09.001_bib5","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41591-021-01235-7","article-title":"A plethora of gene therapies for hemoglobinopathies","volume":"27","author":"Dunbar","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2021.09.001_bib6","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1073\/pnas.93.3.1156","article-title":"Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain","volume":"93","author":"Kim","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2021.09.001_bib7","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ymthe.2019.01.014","article-title":"Genome Editing with mRNA Encoding ZFN, TALEN, and Cas9","volume":"27","author":"Zhang","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2021.09.001_bib8","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJMoa1300662","article-title":"Gene editing of CCR5 in autologous CD4 T\u00a0cells of persons infected with HIV","volume":"370","author":"Tebas","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2021.09.001_bib9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/COH.0b013e32834122d7","article-title":"Chemokine receptor 5 knockout strategies","volume":"6","author":"Cannon","year":"2011","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.ymthe.2021.09.001_bib10","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1182\/blood-2019-125743","article-title":"Preliminary results of a phase 1\/2 clinical study of zinc finger nuclease-mediated editing of BCL11A in autologous hematopoietic stem cells for transfusion-dependent Beta thalassemia","volume":"134","author":"Smith","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2021.09.001_bib11","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/nbt.3408","article-title":"Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors","volume":"33","author":"Wang","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2021.09.001_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-019-0089-y","article-title":"Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects","volume":"5","author":"Li","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2021.09.001_bib13","doi-asserted-by":"crossref","first-page":"e0223775","DOI":"10.1371\/journal.pone.0223775","article-title":"Gene editing of PKLR gene in human hematopoietic progenitors through 5\u2032 and 3\u2032 UTR modified TALEN mRNA","volume":"14","author":"Quintana-Bustamante","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2021.09.001_bib14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.omtm.2018.12.008","article-title":"TALEN-Mediated Gene Editing of HBG in Human Hematopoietic Stem Cells Leads to Therapeutic Fetal Hemoglobin Induction","volume":"12","author":"Lux","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2021.09.001_bib15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.omtm.2017.11.005","article-title":"A Nonhuman Primate Transplantation Model to Evaluate Hematopoietic Stem Cell Gene Editing Strategies for \u03b2-Hemoglobinopathies","volume":"8","author":"Humbert","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2021.09.001_bib16","doi-asserted-by":"crossref","first-page":"100641","DOI":"10.1016\/j.blre.2019.100641","article-title":"Hematopoietic stem cell gene therapy: The optimal use of lentivirus and gene editing approaches","volume":"40","author":"Lamsfus-Calle","year":"2020","journal-title":"Blood Rev."},{"key":"10.1016\/j.ymthe.2021.09.001_bib17","doi-asserted-by":"crossref","first-page":"1258096","DOI":"10.1126\/science.1258096","article-title":"Genome editing. The new frontier of genome engineering with CRISPR-Cas9","volume":"346","author":"Doudna","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2021.09.001_bib18","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2021.09.001_bib19","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.cell.2020.06.018","article-title":"An Engineered CRISPR-Cas9 Mouse Line for Simultaneous Readout of Lineage Histories and Gene Expression Profiles in Single Cells","volume":"181","author":"Bowling","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2021.09.001_bib20","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/s41587-020-0551-y","article-title":"Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking","volume":"38","author":"Ferrari","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2021.09.001_bib21","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41586-020-2503-6","article-title":"Single-cell lineage tracing unveils a role for TCF15 in haematopoiesis","volume":"583","author":"Rodriguez-Fraticelli","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.09.001_bib22","doi-asserted-by":"crossref","first-page":"100247","DOI":"10.1016\/j.xcrm.2021.100247","article-title":"Preclinical evaluation for engraftment of CD34+ cells gene-edited at the sickle cell disease locus in xenograft mouse and non-human primate models","volume":"2","author":"Uchida","year":"2021","journal-title":"Cell Rep. Med"},{"key":"10.1016\/j.ymthe.2021.09.001_bib23","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.2951","article-title":"Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing","volume":"32","author":"Heckl","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2021.09.001_bib24","doi-asserted-by":"crossref","first-page":"eaaw3768","DOI":"10.1126\/scitranslmed.aaw3768","article-title":"Therapeutically relevant engraftment of a CRISPR-Cas9-edited HSC-enriched population with HbF reactivation in nonhuman primates","volume":"11","author":"Humbert","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2021.09.001_bib25","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.ymthe.2017.04.027","article-title":"CRISPR\/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem\/Progenitor Cells Confers HIV-1 Resistance In\u00a0Vivo","volume":"25","author":"Xu","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2021.09.001_bib26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.omtn.2019.05.025","article-title":"In\u00a0Vivo Outcome of Homology-Directed Repair at the HBB Gene in HSC Using Alternative Donor Template Delivery Methods","volume":"17","author":"Pattabhi","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2021.09.001_bib27","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 Gene Editing for Sickle Cell Disease and \u03b2-Thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2021.09.001_bib28","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/nbt1353","article-title":"Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery","volume":"25","author":"Lombardo","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2021.09.001_bib29","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1182\/blood-2014-12-615948","article-title":"Correction of the sickle cell disease mutation in human hematopoietic stem\/progenitor cells","volume":"125","author":"Hoban","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2021.09.001_bib30","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.omtn.2018.05.010","article-title":"VSV-G-Enveloped Vesicles for Traceless Delivery of CRISPR-Cas9","volume":"12","author":"Montagna","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2021.09.001_bib31","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature13420","article-title":"Targeted genome editing in human repopulating haematopoietic stem cells","volume":"510","author":"Genovese","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.09.001_bib32","doi-asserted-by":"crossref","first-page":"14057","DOI":"10.1038\/mtm.2014.57","article-title":"Efficient genome editing in hematopoietic stem cells with helper-dependent Ad5\/35 vectors expressing site-specific endonucleases under microRNA regulation","volume":"1","author":"Saydaminova","year":"2015","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2021.09.001_bib33","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/mt.2013.65","article-title":"Genomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases","volume":"21","author":"Li","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2021.09.001_bib34","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.stem.2020.12.015","article-title":"Dissecting ELANE neutropenia pathogenicity by human HSC gene editing","volume":"28","author":"Rao","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2021.09.001_bib35","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1007\/s00216-010-3821-6","article-title":"Mammalian cell transfection: the present and the future","volume":"397","author":"Kim","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.ymthe.2021.09.001_bib36","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.exphem.2006.05.023","article-title":"Stable gene transfer to human CD34(+) hematopoietic cells using the Sleeping Beauty transposon","volume":"34","author":"Hollis","year":"2006","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.ymthe.2021.09.001_bib37","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.stem.2014.10.004","article-title":"Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR\/Cas9","volume":"15","author":"Mandal","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2021.09.001_bib38","doi-asserted-by":"crossref","first-page":"eaah3480","DOI":"10.1126\/scitranslmed.aah3480","article-title":"CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease","volume":"9","author":"De Ravin","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2021.09.001_bib39","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.celrep.2016.09.092","article-title":"Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR\/Cas9","volume":"17","author":"Gundry","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2021.09.001_bib40","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nbt.3290","article-title":"Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells","volume":"33","author":"Hendel","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2021.09.001_bib41","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ymthe.2018.10.008","article-title":"Optimization of CRISPR\/Cas9 Delivery to Human Hematopoietic Stem and Progenitor Cells for Therapeutic Genomic Rearrangements","volume":"27","author":"Lattanzi","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2021.09.001_bib42","doi-asserted-by":"crossref","first-page":"6677","DOI":"10.1172\/JCI140189","article-title":"BCL11A enhancer-edited hematopoietic stem cells persist in rhesus monkeys without toxicity","volume":"130","author":"Demirci","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2021.09.001_bib43","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41592-018-0149-1","article-title":"Guide Swap enables genome-scale pooled CRISPR-Cas9 screening in human primary cells","volume":"15","author":"Ting","year":"2018","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2021.09.001_bib44","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.omtm.2021.02.022","article-title":"Cas9 protein delivery non-integrating lentiviral vectors for gene correction in sickle cell disease","volume":"21","author":"Uchida","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2021.09.001_bib45","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.3390\/cells9071608","article-title":"Latest Developed Strategies to Minimize the Off-Target Effects in CRISPR-Cas-Mediated Genome Editing","volume":"9","author":"Naeem","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ymthe.2021.09.001_bib46","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1089\/hum.2010.016","article-title":"Enhanced long-term transduction and multilineage engraftment of human hematopoietic stem cells transduced with tyrosine-modified recombinant adeno-associated virus serotype 2","volume":"21","author":"Kauss","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2021.09.001_bib47","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jcyt.2013.04.003","article-title":"Optimizing the transduction efficiency of capsid-modified AAV6 serotype vectors in primary human hematopoietic stem cells in\u00a0vitro and in a xenograft mouse model in\u00a0vivo","volume":"15","author":"Song","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.ymthe.2021.09.001_bib48","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1089\/hum.2020.049","article-title":"Adeno-Associated Virus and Hematopoietic Stem Cells: The Potential of Adeno-Associated Virus Hematopoietic Stem Cells in Genetic Medicines","volume":"31","author":"Chatterjee","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2021.09.001_bib49","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature20134","article-title":"CRISPR\/Cas9 \u03b2-globin gene targeting in human haematopoietic stem cells","volume":"539","author":"Dever","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.09.001_bib50","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/s41467-021-20909-x","article-title":"Cas9-AAV6 gene correction of beta-globin in autologous HSCs improves sickle cell disease erythropoiesis in mice","volume":"12","author":"Wilkinson","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2021.09.001_bib51","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nbt.3513","article-title":"Targeted gene addition in human CD34(+) hematopoietic cells for correction of X-linked chronic granulomatous disease","volume":"34","author":"De Ravin","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2021.09.001_bib52","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/s41467-019-09614-y","article-title":"Gene correction for SCID-X1 in long-term hematopoietic stem cells","volume":"10","author":"Pavel-Dinu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2021.09.001_bib53","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.ymthe.2019.05.014","article-title":"Editing the Sickle Cell Disease Mutation in Human Hematopoietic Stem Cells: Comparison of Endonucleases and Homologous Donor Templates","volume":"27","author":"Romero","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2021.09.001_bib54","doi-asserted-by":"crossref","first-page":"eabf2444","DOI":"10.1126\/scitranslmed.abf2444","article-title":"Development of \u03b2-globin gene correction in human hematopoietic stem cells as a potential durable treatment for sickle cell disease","volume":"13","author":"Lattanzi","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2021.09.001_bib55","doi-asserted-by":"crossref","first-page":"613252","DOI":"10.3389\/fgeed.2020.613252","article-title":"Gene editing and genotoxicity: targeting the off-targets","volume":"2","author":"Blattner","year":"2020","journal-title":"Front. Genome Ed."},{"key":"10.1016\/j.ymthe.2021.09.001_bib56","doi-asserted-by":"crossref","first-page":"9584","DOI":"10.1093\/nar\/gkt714","article-title":"CRISPR\/Cas9 systems targeting \u03b2-globin and CCR5 genes have substantial off-target activity","volume":"41","author":"Cradick","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2021.09.001_bib57","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nbt.3117","article-title":"GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases","volume":"33","author":"Tsai","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2021.09.001_bib58","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nmeth.4278","article-title":"CIRCLE-seq: a highly sensitive in\u00a0vitro screen for genome-wide CRISPR-Cas9 nuclease off-targets","volume":"14","author":"Tsai","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2021.09.001_bib59","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41551-017-0178-6","article-title":"Prediction of off-target activities for the end-to-end design of CRISPR guide RNAs","volume":"2","author":"Listgarten","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ymthe.2021.09.001_bib60","article-title":"Prediction and Validation of Hematopoietic Stem and Progenitor Cell Off-Target Editing in Transplanted Rhesus Macaques","author":"AlJanahi","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2021.09.001_bib61","doi-asserted-by":"crossref","first-page":"eaba7365","DOI":"10.1126\/science.aba7365","article-title":"CRISPR-engineered T\u00a0cells in patients with refractory cancer","volume":"367","author":"Stadtmauer","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2021.09.001_bib62","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41588-021-00838-7","article-title":"Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing","volume":"53","author":"Leibowitz","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2021.09.001_bib63","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/nat.2019.0790","article-title":"Evaluation and Reduction of CRISPR Off-Target Cleavage Events","volume":"29","author":"Vakulskas","year":"2019","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.ymthe.2021.09.001_bib64","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.aad5227","article-title":"Rationally engineered Cas9 nucleases with improved specificity","volume":"351","author":"Slaymaker","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2021.09.001_bib65","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature16526","article-title":"High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects","volume":"529","author":"Kleinstiver","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.09.001_bib66","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/s41591-018-0137-0","article-title":"A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells","volume":"24","author":"Vakulskas","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2021.09.001_bib67","doi-asserted-by":"crossref","first-page":"e1408","DOI":"10.1002\/wsbm.1408","article-title":"Immunity to CRISPR Cas9 and Cas12a therapeutics","volume":"10","author":"Chew","year":"2018","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"key":"10.1016\/j.ymthe.2021.09.001_bib68","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.xphs.2019.10.003","article-title":"Immunogenicity of Cas9 Protein","volume":"109","author":"Mehta","year":"2020","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.ymthe.2021.09.001_bib69","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway","volume":"339","author":"Sun","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2021.09.001_bib70","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1101\/gr.231936.117","article-title":"CRISPR RNAs trigger innate immune responses in human cells","volume":"28","author":"Kim","year":"2018","journal-title":"Genome Res."},{"key":"10.1016\/j.ymthe.2021.09.001_bib71","doi-asserted-by":"crossref","first-page":"e2005840","DOI":"10.1371\/journal.pbio.2005840","article-title":"In\u00a0vitro-transcribed guide RNAs trigger an innate immune response via the RIG-I pathway","volume":"16","author":"Wienert","year":"2018","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ymthe.2021.09.001_bib72","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s13238-018-0605-9","article-title":"In\u00a0vitro transcribed sgRNA causes cell death by inducing interferon release","volume":"10","author":"Mu","year":"2019","journal-title":"Protein Cell"},{"key":"10.1016\/j.ymthe.2021.09.001_bib73","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.stem.2019.02.019","article-title":"Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response","volume":"24","author":"Schiroli","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2021.09.001_bib74","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.yexcr.2014.08.017","article-title":"Pro-inflammatory cytokines: emerging players regulating HSC function in normal and diseased hematopoiesis","volume":"329","author":"Mirantes","year":"2014","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ymthe.2021.09.001_bib75","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.omtn.2020.01.004","article-title":"Development of a Facile Approach for Generating Chemically Modified CRISPR\/Cas9 RNA","volume":"19","author":"Scott","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2021.09.001_bib76","first-page":"121","article-title":"Chemical Modification of CRISPR gRNAs Eliminate type I Interferon Responses in Human Peripheral Blood Mononuclear Cells","volume":"3","author":"Schubert","year":"2018","journal-title":"J.\u00a0Cytokine Biol."},{"key":"10.1016\/j.ymthe.2021.09.001_bib77","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.stem.2018.10.008","article-title":"Cyclosporine H Overcomes Innate Immune Restrictions to Improve Lentiviral Transduction and Gene Editing In Human Hematopoietic Stem Cells","volume":"23","author":"Petrillo","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2021.09.001_bib78","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1016\/j.ymthe.2018.06.002","article-title":"Global Transcriptional Response to CRISPR\/Cas9-AAV6-Based Genome Editing in CD34+ Hematopoietic Stem and Progenitor Cells","volume":"26","author":"Cromer","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2021.09.001_bib79","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","article-title":"Identification of preexisting adaptive immunity to Cas9 proteins in humans","volume":"25","author":"Charlesworth","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2021.09.001_bib80","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.omtm.2018.06.006","article-title":"Prevalence of Pre-existing Antibodies to CRISPR-Associated Nuclease Cas9 in the USA Population","volume":"10","author":"Simhadri","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2021.09.001_bib81","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ymthe.2020.04.017","article-title":"AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9","volume":"28","author":"Li","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2021.09.001_bib82","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/s41551-019-0431-2","article-title":"Immune-orthogonal orthologues of AAV capsids and of Cas9 circumvent the immune response to the administration of gene therapy","volume":"3","author":"Moreno","year":"2019","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ymthe.2021.09.001_bib83","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1089\/hum.2009.182","article-title":"Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors","volume":"21","author":"Boutin","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2021.09.001_bib84","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.omtm.2020.10.002","article-title":"Envelope-Specific Adaptive Immunity following Transplantation of Hematopoietic Stem Cells Modified with VSV-G Lentivirus","volume":"19","author":"Rust","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2021.09.001_bib85","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.omtm.2019.10.010","article-title":"Immunoresponse to Gene-Modified Hematopoietic Stem Cells","volume":"16","author":"Drysdale","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2021.09.001_bib86","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/s41591-019-0550-z","article-title":"Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia","volume":"25","author":"R\u00edo","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2021.09.001_bib87","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.bcmd.2013.12.005","article-title":"DNA damage response in adult stem cells","volume":"52","author":"Insinga","year":"2014","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ymthe.2021.09.001_bib88","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.stem.2010.05.016","article-title":"A distinctive DNA damage response in human hematopoietic stem cells reveals an apoptosis-independent role for p53 in self-renewal","volume":"7","author":"Milyavsky","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2021.09.001_bib89","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.stem.2010.06.014","article-title":"Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis","volume":"7","author":"Mohrin","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2021.09.001_bib90","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41591-018-0049-z","article-title":"CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response","volume":"24","author":"Haapaniemi","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2021.09.001_bib91","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.4049\/jimmunol.2000654","article-title":"p53 Hinders CRISPR\/Cas9-Mediated Targeted Gene Disruption in Memory CD8\u00a0T Cells In\u00a0Vivo","volume":"205","author":"Kurup","year":"2020","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2021.09.001_bib92","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41588-020-0623-4","article-title":"Cas9 activates the p53 pathway and selects for p53-inactivating mutations","volume":"52","author":"Enache","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2021.09.001_bib93","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.15252\/emmm.201707922","article-title":"Lentiviral vectors escape innate sensing but trigger p53 in human hematopoietic stem and progenitor cells","volume":"9","author":"Piras","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2021.09.001_bib94","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nbt.4021","article-title":"Inhibition of 53BP1 favors homology-dependent DNA repair and increases CRISPR-Cas9 genome-editing efficiency","volume":"36","author":"Canny","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2021.09.001_bib95","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1182\/blood.2020008503","article-title":"Enhanced homology-directed repair for highly efficient gene editing in hematopoietic stem\/progenitor cells","volume":"137","author":"De Ravin","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2021.09.001_bib96","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41434-021-00251-z","article-title":"Correction of X-CGD patient HSPCs by targeted CYBB cDNA insertion using CRISPR\/Cas9 with 53BP1 inhibition for enhanced homology-directed repair","volume":"28","author":"Sweeney","year":"2021","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2021.09.001_bib97","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1038\/s41467-019-10735-7","article-title":"CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites","volume":"10","author":"Jayavaradhan","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2021.09.001_bib98","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1089\/hum.2020.247","article-title":"Rational Selection of CRISPR-Cas Triggering Homology-Directed Repair in Human Cells","volume":"32","author":"Li","year":"2021","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2021.09.001_bib99","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.ymthe.2020.10.006","article-title":"Rational Selection of CRISPR-Cas9 Guide RNAs for Homology-Directed Genome Editing","volume":"29","author":"Tatiossian","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2021.09.001_bib100","doi-asserted-by":"crossref","first-page":"7720","DOI":"10.1073\/pnas.1213431110","article-title":"Microhomology-mediated End Joining and Homologous Recombination share the initial end resection step to repair DNA double-strand breaks in mammalian cells","volume":"110","author":"Truong","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2021.09.001_bib101","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1182\/blood.2019000800","article-title":"CRISPR\/Cas9 PIG -A gene editing in nonhuman primate model demonstrates no intrinsic clonal expansion of PNH HSPCs","volume":"133","author":"Shin","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2021.09.001_bib102","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.cell.2018.05.013","article-title":"Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia","volume":"173","author":"Kim","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2021.09.001_bib103","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/nar\/gkaa1251","article-title":"Dynamics and competition of CRISPR-Cas9 ribonucleoproteins and AAV donor-mediated NHEJ, MMEJ and HDR editing","volume":"49","author":"Fu","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2021.09.001_bib104","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nprot.2017.143","article-title":"CRISPR\/Cas9 genome editing in human hematopoietic stem cells","volume":"13","author":"Bak","year":"2018","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2021.09.001_bib105","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.omtn.2019.12.021","article-title":"A Universal Surrogate Reporter for Efficient Enrichment of CRISPR\/Cas9-Mediated Homology-Directed Repair in Mammalian Cells","volume":"19","author":"Yan","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2021.09.001_bib106","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/sctm.20-0520","article-title":"Persistence of CRISPR\/Cas9 gene edited hematopoietic stem cells following transplantation: A systematic review and meta-analysis of preclinical studies","volume":"10","author":"Maganti","year":"2021","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.ymthe.2021.09.001_bib107","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1182\/blood-2015-09-672337","article-title":"Long-term multilineage engraftment of autologous genome-edited hematopoietic stem cells in nonhuman primates","volume":"127","author":"Peterson","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2021.09.001_bib108","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1182\/blood-2016-07-728691","article-title":"Quantitative stability of hematopoietic stem and progenitor cell clonal output in rhesus macaques receiving transplants","volume":"129","author":"Koelle","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2021.09.001_bib109","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1182\/blood-2007-09-115022","article-title":"Efficient transduction of pigtailed macaque hematopoietic repopulating cells with HIV-based lentiviral vectors","volume":"111","author":"Trobridge","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2021.09.001_bib110","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1053\/j.seminhematol.2013.03.025","article-title":"Hematopoietic stem cell gene therapy:assessing the relevance of preclinical models","volume":"50","author":"Larochelle","year":"2013","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.ymthe.2021.09.001_bib111","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/bjh.17175","article-title":"Clonal tracking of haematopoietic cells: insights and clinical implications","volume":"192","author":"Cordes","year":"2021","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymthe.2021.09.001_bib112","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/s41467-020-20792-y","article-title":"The TRACE-Seq method tracks recombination alleles and identifies clonal reconstitution dynamics of gene targeted human hematopoietic stem cells","volume":"12","author":"Sharma","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2021.09.001_bib113","doi-asserted-by":"crossref","first-page":"108093","DOI":"10.1016\/j.celrep.2020.108093","article-title":"Controlled Cycling and Quiescence Enables Efficient HDR in Engraftment-Enriched Adult Hematopoietic Stem and Progenitor Cells","volume":"32","author":"Shin","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2021.09.001_bib114","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.omtm.2020.07.010","article-title":"Purification of Human CD34+CD90+ HSCs Reduces Target Cell Population and Improves Lentiviral Transduction for Gene Therapy","volume":"18","author":"Radtke","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2021.09.001_bib115","doi-asserted-by":"crossref","first-page":"e13545","DOI":"10.15252\/emmm.202013545","article-title":"Modeling, optimization, and comparable efficacy of T\u00a0cell and hematopoietic stem cell gene editing for treating hyper-IgM syndrome","volume":"13","author":"Vavassori","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2021.09.001_bib116","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.09.001_bib117","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41576-018-0059-1","article-title":"Base editing: precision chemistry on the genome and transcriptome of living cells","volume":"19","author":"Rees","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ymthe.2021.09.001_bib118","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/s41596-020-00450-9","article-title":"Precision genome editing using cytosine and adenine base editors in mammalian cells","volume":"16","author":"Huang","year":"2021","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2021.09.001_bib119","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41591-020-0790-y","article-title":"Therapeutic base editing of human hematopoietic stem cells","volume":"26","author":"Zeng","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2021.09.001_bib120","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41586-021-03609-w","article-title":"Base editing of haematopoietic stem cells rescues sickle cell disease in mice","volume":"595","author":"Newby","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.09.001_bib121","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1089\/crispr.2020.0144","article-title":"Rationally Designed Base Editors for Precise Editing of the Sickle Cell Disease Mutation","volume":"4","author":"Chu","year":"2021","journal-title":"CRISPR J."},{"key":"10.1016\/j.ymthe.2021.09.001_bib122","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1126\/science.aav9973","article-title":"Cytosine base editor generates substantial off-target single-nucleotide variants in mouse embryos","volume":"364","author":"Zuo","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2021.09.001_bib123","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1126\/science.aaw7166","article-title":"Cytosine, but not adenine, base editors induce genome-wide off-target mutations in rice","volume":"364","author":"Jin","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2021.09.001_bib124","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.09.001_bib125","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3390\/genes11050511","article-title":"Efficient Generation and Correction of Mutations in Human iPS Cells Utilizing mRNAs of CRISPR Base Editors and Prime Editors","volume":"11","author":"S\u00fcr\u00fcn","year":"2020","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.ymthe.2021.09.001_bib126","article-title":"CRISPR prime editing with ribonucleoprotein complexes in zebrafish and primary human cells","author":"Petri","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2021.09.001_bib127","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1038\/mt.2014.107","article-title":"Gene transfer properties and structural modeling of human stem cell-derived AAV","volume":"22","author":"Smith","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2021.09.001_bib128","doi-asserted-by":"crossref","first-page":"E7379","DOI":"10.1073\/pnas.1802343115","article-title":"Stem cell-derived clade F AAVs mediate high-efficiency homologous recombination-based genome editing","volume":"115","author":"Smith","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2021.09.001_bib129","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.ymthe.2019.08.019","article-title":"Homologous Recombination-Based Genome Editing by Clade F AAVs Is Inefficient in the Absence of a Targeted DNA Break","volume":"27","author":"Rogers","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2021.09.001_bib130","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.ymthe.2019.09.005","article-title":"AAV6 Is Superior to Clade F AAVs in Stimulating Homologous Recombination-Based Genome Editing in Human HSPCs","volume":"27","author":"Dudek","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2021.09.001_bib131","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/j.ymthe.2019.11.002","article-title":"Efficient Nuclease-free HR by Clade F AAV Requires High MOIs with High Quality Vectors","volume":"27","author":"Chatterjee","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2021.09.001_bib132","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1182\/blood-2009-01-201335","article-title":"Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation","volume":"113","author":"Hoggatt","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2021.09.001_bib133","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ymthe.2017.09.025","article-title":"Prostaglandin E2 Increases Lentiviral Vector Transduction Efficiency of Adult Human Hematopoietic Stem and Progenitor Cells","volume":"26","author":"Heffner","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2021.09.001_bib134","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.stem.2011.02.003","article-title":"Prostaglandin E2 enhances human cord blood stem cell xenotransplants and shows long-term safety in preclinical nonhuman primate transplant models","volume":"8","author":"Goessling","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2021.09.001_bib135","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1126\/science.1191536","article-title":"Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells","volume":"329","author":"Boitano","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2021.09.001_bib136","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.stem.2015.10.004","article-title":"Phase I\/II Trial of StemRegenin-1 Expanded Umbilical Cord Blood Hematopoietic Stem Cells Supports Testing as a Stand-Alone Graft","volume":"18","author":"Wagner","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2021.09.001_bib137","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1126\/science.1256337","article-title":"Cord blood expansion. Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal","volume":"345","author":"Fares","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2021.09.001_bib138","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1016\/S2352-3026(19)30202-9","article-title":"Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study","volume":"7","author":"Cohen","year":"2020","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.ymthe.2021.09.001_bib139","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1158\/0008-5472.CAN-04-3063","article-title":"Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells","volume":"65","author":"De Felice","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2021.09.001_bib140","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/sctm.19-0199","article-title":"Expansion and preservation of the functional activity of adult hematopoietic stem cells cultured ex\u00a0vivo with a histone deacetylase inhibitor","volume":"9","author":"Zimran","year":"2020","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.ymthe.2021.09.001_bib141","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1182\/bloodadvances.2018024273","article-title":"Ex\u00a0vivo human HSC expansion requires coordination of cellular reprogramming with mitochondrial remodeling and p53 activation","volume":"2","author":"Papa","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2021.09.001_bib142","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1182\/blood-2005-03-1081","article-title":"Human short-term repopulating stem cells are efficiently detected following intrafemoral transplantation into NOD\/SCID recipients depleted of CD122+ cells","volume":"106","author":"McKenzie","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2021.09.001_bib143","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41591-018-0301-6","article-title":"Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent \u00df-thalassemia","volume":"25","author":"Marktel","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2021.09.001_bib144","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.1182\/bloodadvances.2020003040","article-title":"Intrabone transplantation of CD34+ cells with optimized delivery does not enhance engraftment in a rhesus macaque model","volume":"4","author":"Stringaris","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2021.09.001_bib145","first-page":"1185","article-title":"Baseline TP53 mutations in adults with SCD developing myeloid malignancy following hematopoietic cell transplantation","volume":"135","author":"Ghannam","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2021.09.001_bib146","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1182\/bloodadvances.2019001330","article-title":"Myelodysplastic syndrome unrelated to lentiviral vector in a patient treated with gene therapy for sickle cell disease","volume":"4","author":"Hsieh","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2021.09.001_bib147","first-page":"101","article-title":"Updated Results from HGB-206 LentiGlobin for Sickle Cell Disease Gene Therapy Study: Group C Data and Group A AML Case Investigation","volume":"29","author":"Tisdale","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2021.09.001_bib148","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.ymthe.2021.03.010","article-title":"A pause in gene therapy: Reflecting on the unique challenges of sickle cell disease","volume":"29","author":"Leonard","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2021.09.001_bib149","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1182\/blood-2018-06-858159","article-title":"Anti-CD117 antibody depletes normal and myelodysplastic syndrome human hematopoietic stem cells in xenografted mice","volume":"133","author":"Pang","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2021.09.001_bib150","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1016\/j.bbmt.2018.12.172","article-title":"Toxicity-free hematopoietic stem cell engraftment achieved with anti-CD117 monoclonal antibody conditioning","volume":"25","author":"Agarwal","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.ymthe.2021.09.001_bib151","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41467-018-08201-x","article-title":"Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation","volume":"10","author":"Czechowicz","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2021.09.001_bib152","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.exphem.2021.01.003","article-title":"Anti-CD117 immunotherapy to eliminate hematopoietic and leukemia stem cells","volume":"95","author":"Russkamp","year":"2021","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.ymthe.2021.09.001_bib153","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1089\/hum.2020.263","article-title":"Safe and Effective In\u00a0Vivo Targeting and Gene Editing in Hematopoietic Stem Cells: Strategies for Accelerating Development","volume":"32","author":"Cannon","year":"2021","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2021.09.001_bib154","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.omtm.2018.02.004","article-title":"Integrating HDAd5\/35++ Vectors as a New Platform for HSC Gene Therapy of Hemoglobinopathies","volume":"9","author":"Li","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2021.09.001_bib155","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1172\/JCI122836","article-title":"In\u00a0vivo hematopoietic stem cell gene therapy ameliorates murine thalassemia intermedia","volume":"129","author":"Wang","year":"2019","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2021.09.001_bib156","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ymthe.2020.09.001","article-title":"In\u00a0Vivo HSC Gene Therapy Using a Bi-modular HDAd5\/35++ Vector Cures Sickle Cell Disease in a Mouse Model","volume":"29","author":"Li","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2021.09.001_bib157","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1182\/blood-2013-11-538926","article-title":"Intravenous injection of a foamy virus vector to correct canine SCID-X1","volume":"123","author":"Burtner","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2021.09.001_bib158","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.stem.2021.01.001","article-title":"Hematopoietic-Stem-Cell-Targeted Gene-Addition and Gene-Editing Strategies for \u03b2-hemoglobinopathies","volume":"28","author":"Drysdale","year":"2021","journal-title":"Cell Stem Cell"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001621004561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001621004561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T18:53:55Z","timestamp":1714589635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001621004561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":158,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1525001621004561"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2021.09.001","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding and overcoming adverse consequences of genome editing on hematopoietic stem and progenitor cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2021.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}